{"nct_id":"NCT00695448","title":"Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma","status":"TERMINATED","status_verified_date":"2017-07","start_date":"2008-06-24","start_date_type":"ACTUAL","primary_completion_date":"2009-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2009-03-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}